These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1242 related articles for article (PubMed ID: 27836629)

  • 1. Mitochondrial dysfunction and oxidative stress in metabolic disorders - A step towards mitochondria based therapeutic strategies.
    Bhatti JS; Bhatti GK; Reddy PH
    Biochim Biophys Acta Mol Basis Dis; 2017 May; 1863(5):1066-1077. PubMed ID: 27836629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic Strategies for Mitochondrial Dysfunction and Oxidative Stress in Age-Related Metabolic Disorders.
    Bhatti JS; Kumar S; Vijayan M; Bhatti GK; Reddy PH
    Prog Mol Biol Transl Sci; 2017; 146():13-46. PubMed ID: 28253984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial biogenesis: pharmacological approaches.
    Valero T
    Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Linking mitochondrial dysfunction, metabolic syndrome and stress signaling in Neurodegeneration.
    Jha SK; Jha NK; Kumar D; Ambasta RK; Kumar P
    Biochim Biophys Acta Mol Basis Dis; 2017 May; 1863(5):1132-1146. PubMed ID: 27345267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The renin angiotensin system, oxidative stress and mitochondrial function in obesity and insulin resistance.
    Ramalingam L; Menikdiwela K; LeMieux M; Dufour JM; Kaur G; Kalupahana N; Moustaid-Moussa N
    Biochim Biophys Acta Mol Basis Dis; 2017 May; 1863(5):1106-1114. PubMed ID: 27497523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial Dysfunction, Oxidative Stress, and Therapeutic Strategies in Diabetes, Obesity, and Cardiovascular Disease.
    Cojocaru KA; Luchian I; Goriuc A; Antoci LM; Ciobanu CG; Popescu R; Vlad CE; Blaj M; Foia LG
    Antioxidants (Basel); 2023 Mar; 12(3):. PubMed ID: 36978905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targetable Pathways for Alleviating Mitochondrial Dysfunction in Neurodegeneration of Metabolic and Non-Metabolic Diseases.
    Millichap LE; Damiani E; Tiano L; Hargreaves IP
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenic mitochondrial dysfunction and metabolic abnormalities.
    Moos WH; Faller DV; Glavas IP; Harpp DN; Kamperi N; Kanara I; Kodukula K; Mavrakis AN; Pernokas J; Pernokas M; Pinkert CA; Powers WR; Steliou K; Tamvakopoulos C; Vavvas DG; Zamboni RJ; Sampani K
    Biochem Pharmacol; 2021 Nov; 193():114809. PubMed ID: 34673016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondria in metabolic disease: getting clues from proteomic studies.
    Peinado JR; Diaz-Ruiz A; Frühbeck G; Malagon MM
    Proteomics; 2014 Mar; 14(4-5):452-66. PubMed ID: 24339000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aldosterone, mitochondria and regulation of cardiovascular metabolic disease.
    Tsai CH; Chen ZW; Lee BC; Liao CW; Chang YY; Tsai YR; Chou CH; Wu VC; Hung CS; Lin YH
    J Endocrinol; 2024 Oct; 263(1):. PubMed ID: 39121045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial dysfunction and its impact on diabetic heart.
    Verma SK; Garikipati VNS; Kishore R
    Biochim Biophys Acta Mol Basis Dis; 2017 May; 1863(5):1098-1105. PubMed ID: 27593695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial Dysfunction in Age-Related Metabolic Disorders.
    Natarajan V; Chawla R; Mah T; Vivekanandan R; Tan SY; Sato PY; Mallilankaraman K
    Proteomics; 2020 Mar; 20(5-6):e1800404. PubMed ID: 32131138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting mitochondria as therapeutic strategy for metabolic disorders.
    Sorriento D; Pascale AV; Finelli R; Carillo AL; Annunziata R; Trimarco B; Iaccarino G
    ScientificWorldJournal; 2014; 2014():604685. PubMed ID: 24757426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of mitochondria and NADPH oxidase function by the nitrate-nitrite-NO pathway in metabolic disease with focus on type 2 diabetes.
    Schiffer TA; Lundberg JO; Weitzberg E; Carlström M
    Biochim Biophys Acta Mol Basis Dis; 2020 Aug; 1866(8):165811. PubMed ID: 32339643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crosstalk Between Mitochondrial Hyperacetylation and Oxidative Stress in Vascular Dysfunction and Hypertension.
    Dikalov SI; Dikalova AE
    Antioxid Redox Signal; 2019 Oct; 31(10):710-721. PubMed ID: 30618267
    [No Abstract]   [Full Text] [Related]  

  • 16. Significance of mitochondria on cardiometabolic syndromes.
    Anupama N; Sindhu G; Raghu KG
    Fundam Clin Pharmacol; 2018 Aug; 32(4):346-356. PubMed ID: 29453877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial Dysfunction and Oxidative Stress in Liver Transplantation and Underlying Diseases: New Insights and Therapeutics.
    Shi S; Wang L; van der Laan LJW; Pan Q; Verstegen MMA
    Transplantation; 2021 Nov; 105(11):2362-2373. PubMed ID: 33577251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Common neurodegenerative pathways in obesity, diabetes, and Alzheimer's disease.
    Pugazhenthi S; Qin L; Reddy PH
    Biochim Biophys Acta Mol Basis Dis; 2017 May; 1863(5):1037-1045. PubMed ID: 27156888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Essential Element Manganese, Oxidative Stress, and Metabolic Diseases: Links and Interactions.
    Li L; Yang X
    Oxid Med Cell Longev; 2018; 2018():7580707. PubMed ID: 29849912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptional activation of antioxidant gene expression by Nrf2 protects against mitochondrial dysfunction and neuronal death associated with acute and chronic neurodegeneration.
    Goodfellow MJ; Borcar A; Proctor JL; Greco T; Rosenthal RE; Fiskum G
    Exp Neurol; 2020 Jun; 328():113247. PubMed ID: 32061629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 63.